Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...
Main Authors: | Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Taylor & Francis Group
2017-04-01
|
סדרה: | Expert Review of Vaccines |
נושאים: | |
גישה מקוונת: | http://dx.doi.org/10.1080/14760584.2017.1294068 |
פריטים דומים
-
Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
מאת: Piyada Angsuwatcharakon, et al.
יצא לאור: (2018-02-01) -
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
מאת: Jia Li, et al.
יצא לאור: (2024-12-01) -
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
מאת: D.J. Briggs, et al. -
Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
מאת: Jing Wang, et al.
יצא לאור: (2017-01-01) -
DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
מאת: A. L. Kravtsov, et al.
יצא לאור: (2019-08-01)